Healthcare
·
Biotechnology
EXEL added 5.5% for the week on 18.2M shares, keeping its 13-week Trend Signal active, but the move comes with valuation distance and a neutral expectancy read.
Healthcare
·
Drug Manufacturers - Specialty & Generic
NBIX closed within 0.6% of its 52-week high after a 6.5% week, but participation was only modest and the Sharemaestro read remains balanced rather than decisive.
Healthcare
·
Diagnostics & Research
Natera jumped 13.2% for the week and finished just 3.5% below its 52-week high, but the Healthcare diagnostics stock still sits in an early recovery watch rather than a confirmed weekly trend regime.
Healthcare
·
Diagnostics & Research
DGX gained 7.6% for the week and finished just 1.3% below its 52-week high, but participation remained only modestly above its recent baseline.
Healthcare
·
Drug Manufacturers - General
MRK closed at $128.70 after a high-range advance on 64.4M shares, with the weekly Trend Signal still active but Market Dynamics short of a fresh buy confirmation.
Healthcare
·
Biotechnology
INCY rallied 15.8% for the week and closed at $113.8, only 1.6% below its 52-week high, but the weekly Trend Signal remains inactive and Fair Value distance is stretched.
Healthcare
·
Drug Manufacturers - General
JNJ jumped 11.5% to finish just 0.2% below its 52-week high, but negative activity pressure and a 52% Fair Value premium keep the weekly setup from being one-sided.
Healthcare
·
Biotechnology
AXSM slipped 1.8% for the week but remains only 3.7% below its 52-week high, leaving a constructive trend intact while confirmation has become less forceful.
Healthcare
·
Biotechnology
RPRX remains in an active weekly Trend Signal and sits 15.4% above its Trend Line, but a 3.5% weekly fall, fading pressure and average volume leave the latest read more balanced than bullish.
Healthcare
·
Medical Care Facilities
The dialysis operator remains in an active weekly trend and close to its 52-week high, but the latest pullback, sub-average turnover and an undecided expectancy read argue for a more selective interpretation of the move.
Healthcare
·
Biotechnology
JAZZ has cooled from a near-high run, with volume and Market Dynamics no longer confirming the earlier advance even as the weekly trend remains constructive.
Healthcare
·
Healthcare Plans
Elevance Health remains above its weekly Trend Line, but the latest pullback left it trailing a strongly supported Healthcare Plans group and still below Sharemaestro Fair Value.
Healthcare
·
Biotechnology
MRNA closed at 63.96 after a sharp weekly advance, ranking first in US Healthcare and US Biotechnology, but the Sharemaestro read remains balanced as activity pressure stays negative.
Healthcare
·
Biotechnology
ROIV ended the week at $31.43, only 4.2% below its 52-week high, but the latest move came on 0.9x average volume and a negative activity-pressure read.
Healthcare
·
Diagnostics & Research
The precision-oncology diagnostics stock added 4.8% in the latest week and is now 2.0% below its 52-week high, but participation has not yet matched the strength of the price move.